Document is current
Any future updates will be listed below
-
Authors
Derksen, Jeroen W. G.
Vink, Geraldine R.
Elferink, Marloes A. G.
Roodhart, Jeanine M. L.
Verkooijen, Helena M.
van Grevenstein, Wilhelmina M. U.
Siersema, Peter D.
May, Anne M.
Koopman, Miriam
,
Beets, Geerard L.
Belt, Eric J. Th.
Berbée, Maaike
Beverdam, Frederique H.
Blankenburgh, Ruud
Coene, Peter Paul L. O.
van Cruijsen, Hester
Dekker, Jan Willem T.
van Dodewaard-de Jong, Joyce M.
Erdkamp, Frans L. G.
de Groot, Jan Willem B.
Haringhuizen, Annebeth W.
Helgason, Helgi H.
Hendriks, Mathijs P.
de Hingh, Ignace H. J. T.
Hoekstra, Ronald
Ijzermans, Jan N. M.
Jansen, Jan
Kloppenberg, Frank W. H.
van Lent, Anja U. G.
Los, Maartje
Meijerink, Martijn R.
Mekenkamp, Leonie J. M.
Nieboer, Peter
Peeters, Koen C. M. J.
Peters, Natascha A. J. B.
Polée, Marco B.
Pruijt, Johannes F. M.
Punt, Cornelis J. A.
van Ufford-Mannesse, Patricia Quarles
Rietbroek, Ron C.
Schiphorst, Anandi H. W.
van der Velden, Arjan Schouten
Schrauwen, Ruud W. M.
Sie, Mark P. S.
Simkens, Lieke
Sommeijer, Dirkje W.
Sonneveld, Dirk J. A.
Spierings, Leontine E. A.
Stockmann, Hein B. A. C.
Talsma, Koen
Terheggen, Frederiek
ten Tije, Albert J.
Tjin-A-Ton, Manuel L. R.
Valkenburg-van Iersel, Liselot B. J.
Veenstra, Renzo P.
van der Velden, Ankie M. T.
Vermaas, Maarten
Vles, Wouter J.
Vogelaar, Jeroen F. J.
van Voorthuizen, Theo
de Vos, Aad I.
Wegdam, Johannes A.
de Wilt, Johannes H. W.
Zimmerman, David D. E.
- License Information
-
More Information
Article History
Received: 20 July 2020
Accepted: 10 December 2020
First Online: 16 February 2021
Competing interests
: MK reports institutional financial interests with Amgen, Bayer, BMS, Merck-Serono, Nordic Pharma, Roche, Servier, Sirtex, and Sanofi-Aventis. MK reports the following non-financial interests: an advisory role for ZON-MW, membership of the scientific board of the Dutch Cancer Society (KWF), chairmanship of the Dutch Colorectal Cancer Group (DCCG), principal investigator (PI) of the Prospective Dutch Colorectal Cancer (PLCRC) cohort. GRV reports institutional financial interests with Servier, Merck, Bayer, Sirtex, BMS, and Lilly. JMLR reports institutional financial interests with Servier, Merck, and Bayer. PDS reports institutional financial interests with The eNose Company, Norgine, and Motus GI. JWGD, MAGE, HMV, WMUG, and AMM report no competing interests.
